Skip to content

Organon OGN Current ratio

Current ratio at other companies

Pfizer logo
PfizerPFE
1.2×0.0×
Amgen logo
AmgenAMGN
1.3×+0.1×
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
1.3×-0.8×
Biogen logo
BiogenBIIB
3.1×+1.6×
AbbVie logo
AbbVieABBV
0.8×0.0×
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
2.5×+1.1×

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%
Enterprise value$10.98B-26.4%
P/E6.6×+2.1×
P/S0.6×-0.8×

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×

Where this comes from

Calculated from Organon’s reported figures.

Based on the most recent quarter.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's current ratio?
Organon (OGN) reported current ratio of 2× in Q1 2026.
How has Organon's current ratio changed year-over-year?
Organon's current ratio increased by 18.0% year-over-year, from 1.7× to 2×.
What is the long-term trend for Organon's current ratio?
Over 5 years (2020 to 2025), Organon's current ratio has grown at a 6.4% compound annual growth rate (CAGR), from 1.3× to 1.8×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.